J3F-29580-20597
2 vaccinations
5 coded responses
16 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 05-11
- ZIP prefix
- 480 / MI
- Registered
- 2021-12-14
- Relationship
- Child or adolescent in my care
- Guardian
- DRJ-23214-78817
- Race
- White
- Ethnicity
- N/A
Timeline
-
2021-12-12
Dose 1 — Pfizer-BioNTech
-
2021-12-14
Registered in v-safe
-
2021-12-14
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-12-15
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Good · Site: Pain · NoneAdult check-in
-
2021-12-16
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-12-17
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Good · Fatigue or tirednessAdult check-in
-
2021-12-18
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Fair · Fatigue or tirednessAdult check-in
- 2021-12-19
- 2021-12-26
-
2022-01-02
Dose 2 — Pfizer-BioNTech
- 2022-01-02
- 2022-01-16
-
2022-01-23
Survey response — day 21, dose 2, dependentMedDRA: Rash, Rash erythematous, Reaction to previous exposure to any vaccine — Feeling: GoodFree text: She has a red rash on her upper legs. I did not report it when she 1st got it after her initial vaccination because she has something similar but not red on her upper arms so I thought it was that same thing.MedDRA releases: 2024-11 · check-in free text available
-
2022-02-01
Survey response — day 28, dose 2, dependentMedDRA: Rash — Feeling: GoodFree text: Still has wide rash across upper legs and the backs of arms.MedDRA releases: 2024-11 · check-in free text available
- 2022-02-07
- 2022-02-13
-
2022-04-03
Survey response — 3 months, dose 2, dependentMedDRA: Rash — Feeling: GoodFree text: RashMedDRA releases: 2024-11 · check-in free text available
-
2022-07-03
Survey response — 6 months, dose 2, dependentMedDRA: Fatigue, Pyrexia — Feeling: Good · Be unable to work or attend schoolFree text: Fever, fatigueMedDRA releases: 2024-11 · check-in free text available
-
2023-01-02
Survey response — 12 months, dose 2, dependentMedDRA: COVID-19 — Feeling: Fair · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-12-12 | Pfizer-BioNTech | No |
| 2 | 2022-01-02 | Pfizer-BioNTech | No |
Free text
Release 11 — day 21, dose 2, dependent
Symptoms: She has a red rash on her upper legs. I did not report it when she 1st got it after her initial vaccination because she has something similar but not red on her upper arms so I thought it was that same thing.
Release 11 — day 28, dose 2, dependent
Symptoms: Still has wide rash across upper legs and the backs of arms.
Release 11 — 3 months, dose 2, dependent
Symptoms: Rash
Release 12 — 6 months, dose 2, dependent
Symptoms: Fever, fatigue
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rash | · | · | ✓ |
| SD | Rash erythematous | · | · | ✓ |
| SD | Reaction to previous exposure to any vaccine | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release